Randomized Phase 2/3 Trial of CpG Oligodeoxynucleotide PF-3512676 Alone or With Dacarbazine for Patients With Unresectable Stage III and IV Melanoma

J.S. Weber, H. Zarour, B. Redman, U. Trefzer, S. O'Day, A.J.M. van den Eertwegh, E. Marshall, S. Wagner

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)3944-3954
JournalCancer
Volume115
Issue number17
DOIs
Publication statusPublished - 2009

Cite this